Table of Contents
1 Market Overview
1.1 Parathyroid Hormone Analog Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Parathyroid Hormone Analog Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Abaloparatide
1.2.3 Teriparatide
1.2.4 Human Parathyroid Hormone Recombinant
1.3 Market Analysis by Application
1.3.1 Overview: Global Parathyroid Hormone Analog Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Overview of Global Parathyroid Hormone Analog Market
1.4.1 Global Parathyroid Hormone Analog Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Cell Genesys Inc
2.2.1 Cell Genesys Inc Details
2.2.2 Cell Genesys Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Cell Genesys Inc SWOT Analysis
2.2.4 Cell Genesys Inc Product and Services
2.2.5 Cell Genesys Inc Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Natpara
2.3.1 Natpara Details
2.3.2 Natpara Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Natpara SWOT Analysis
2.3.4 Natpara Product and Services
2.3.5 Natpara Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Abbott Laboratories
2.4.1 Abbott Laboratories Details
2.4.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Abbott Laboratories SWOT Analysis
2.4.4 Abbott Laboratories Product and Services
2.4.5 Abbott Laboratories Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Eli Lilly SWOT Analysis
2.5.4 Eli Lilly Product and Services
2.5.5 Eli Lilly Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck SWOT Analysis
2.6.4 Merck Product and Services
2.6.5 Merck Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Paladin Labs Inc
2.7.1 Paladin Labs Inc Details
2.7.2 Paladin Labs Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Paladin Labs Inc SWOT Analysis
2.7.4 Paladin Labs Inc Product and Services
2.7.5 Paladin Labs Inc Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Sanofi SA
2.8.1 Sanofi SA Details
2.8.2 Sanofi SA Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Sanofi SA SWOT Analysis
2.8.4 Sanofi SA Product and Services
2.8.5 Sanofi SA Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 GlaxoSmithKline Plc
2.9.1 GlaxoSmithKline Plc Details
2.9.2 GlaxoSmithKline Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 GlaxoSmithKline Plc SWOT Analysis
2.9.4 GlaxoSmithKline Plc Product and Services
2.9.5 GlaxoSmithKline Plc Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 OSI Pharmaceuticals
2.10.1 OSI Pharmaceuticals Details
2.10.2 OSI Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 OSI Pharmaceuticals SWOT Analysis
2.10.4 OSI Pharmaceuticals Product and Services
2.10.5 OSI Pharmaceuticals Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 ALZA Corporation
2.11.1 ALZA Corporation Details
2.11.2 ALZA Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 ALZA Corporation SWOT Analysis
2.11.4 ALZA Corporation Product and Services
2.11.5 ALZA Corporation Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Parathyroid Hormone Analog Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Parathyroid Hormone Analog Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Parathyroid Hormone Analog Manufacturer Market Share in 2019
3.3.2 Top 6 Parathyroid Hormone Analog Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Parathyroid Hormone Analog Sales, Revenue and Market Share by Regions
4.1.1 Global Parathyroid Hormone Analog Sales and Market Share by Regions (2015-2020)
4.1.2 Global Parathyroid Hormone Analog Revenue and Market Share by Regions (2015-2020)
4.2 North America Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
4.3 Europe Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
4.5 South America Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Parathyroid Hormone Analog Sales, Revenue and Market Share by Country
5.1.1 North America Parathyroid Hormone Analog Sales and Market Share by Country (2015-2020)
5.1.2 North America Parathyroid Hormone Analog Revenue and Market Share by Country (2015-2020)
5.2 United States Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
5.3 Canada Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
5.4 Mexico Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Parathyroid Hormone Analog Sales, Revenue and Market Share by Country
6.1.1 Europe Parathyroid Hormone Analog Sales and Market Share by Country (2015-2020)
6.1.2 Europe Parathyroid Hormone Analog Revenue and Market Share by Country (2015-2020)
6.2 Germany Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
6.3 UK Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
6.4 France Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
6.5 Russia Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
6.6 Italy Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Parathyroid Hormone Analog Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Parathyroid Hormone Analog Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Parathyroid Hormone Analog Revenue and Market Share by Regions (2015-2020)
7.2 China Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
7.3 Japan Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
7.4 Korea Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
7.5 India Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
7.7 Australia Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Parathyroid Hormone Analog Sales, Revenue and Market Share by Country
8.1.1 South America Parathyroid Hormone Analog Sales and Market Share by Country (2015-2020)
8.1.2 South America Parathyroid Hormone Analog Revenue and Market Share by Country (2015-2020)
8.2 Brazil Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
8.3 Argentina Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Parathyroid Hormone Analog Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Parathyroid Hormone Analog Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Parathyroid Hormone Analog Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
9.3 Turkey Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
9.4 Egypt Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
9.5 South Africa Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Parathyroid Hormone Analog Sales and Market Share by Type (2015-2020)
10.2 Global Parathyroid Hormone Analog Revenue and Market Share by Type (2015-2020)
10.3 Global Parathyroid Hormone Analog Price by Type (2015-2020)
11 Global Parathyroid Hormone Analog Market Segment by Application
11.1 Global Parathyroid Hormone Analog Sales Market Share by Application (2015-2020)
11.2 Global Parathyroid Hormone Analog Revenue Market Share by Application (2015-2020)
11.3 Global Parathyroid Hormone Analog Price by Application (2015-2020)
12 Market Forecast
12.1 Global Parathyroid Hormone Analog Sales, Revenue and Growth Rate (2021-2025)
12.2 Parathyroid Hormone Analog Market Forecast by Regions (2021-2025)
12.2.1 North America Parathyroid Hormone Analog Market Forecast (2021-2025)
12.2.2 Europe Parathyroid Hormone Analog Market Forecast (2021-2025)
12.2.3 Asia-Pacific Parathyroid Hormone Analog Market Forecast (2021-2025)
12.2.4 South America Parathyroid Hormone Analog Market Forecast (2021-2025)
12.2.5 Middle East & Africa Parathyroid Hormone Analog Market Forecast (2021-2025)
12.3 Parathyroid Hormone Analog Market Forecast by Type (2021-2025)
12.3.1 Global Parathyroid Hormone Analog Sales Forecast by Type (2021-2025)
12.3.2 Global Parathyroid Hormone Analog Market Share Forecast by Type (2021-2025)
12.4 Parathyroid Hormone Analog Market Forecast by Application (2021-2025)
12.4.1 Global Parathyroid Hormone Analog Sales Forecast by Application (2021-2025)
12.4.2 Global Parathyroid Hormone Analog Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
【掲載企業】
Pfizer、Cell Genesys Inc、Natpara、Abbott Laboratories、Eli Lilly、Merck、Paladin Labs Inc、Sanofi SA、GlaxoSmithKline Plc、OSI Pharmaceuticals、ALZA Corporation、
【免責事項】
https://www.globalresearch.jp/disclaimer